未找到相关数据
EORTC 18991 phase III trial: Long-term adjuvant pegylated interferon-α2b (PEG-IFN) versus observation in resected stage III melanoma: Long-term results at 7.6-years follow-up
被引：14
作者：
Eggermont, A. M.
Suciu, S.
Santinami, M.
Kruit, W.
Testori, A.
Marsden, J.
Punt, C. J. A.
Gore, M. E.
MacKie, R.
Dummer, R.
Schadendorf, D.
Patel, P.
Spatz, A.
Keilholz, U.
机构：
[1] Canc Inst Gustave Roussy, Villejuif, France
[2] EORTC Headquarters, Brussels, Belgium
[3] Surg Oncol Natl Canc Inst, Milan, Italy
[4] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[5] European Inst Oncol, Milan, Italy
[6] Univ Birmingham, Birmingham, W Midlands, England
[7] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[8] Royal Marsden Hosp, London SW3 6JJ, England
[9] Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland
[10] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[11] Univ Hosp Essen, Essen, Germany
[12] Univ Nottingham, Nottingham NG7 2RD, England
[13] McGill Univ, Montreal, PQ, Canada
[14] CBF, Charite, Dept Hematol & Med Oncol, Berlin, Germany
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.8506b
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 [肿瘤学];
摘要：
8506b
引用
收藏
页数：1
相关论文